Precision BioSciences, Inc.

NASDAQ:DTIL

Biotechnology

Healthcare
$7.10 +1.69%

+$0.11 today

Market cap
$198.34M
Beta
1.28
P/E (TTM)
-1.9
EPS (TTM)
-$3.47
52W Low $3.53High $8.82

Volume 0.37M

Average 0.31M

DTIL Other Income / Expenses

Net non-operating gains and losses, such as investment results, currency effects, and one-off items.

Precision BioSciences, Inc.NASDAQ: DTIL

Other Income / Expenses · Q1 FY2026 · quarter ended Mar 2026

Other income / expenses turns negative

Q1 FY2026 other income / expenses was -$9.37M, compared with $1.55M a year earlier. Trailing-twelve-month other income / expenses was -$5.37M.

Context

  • Other income / expenses amounted to 16.2% of revenue in FY2025, down 32.4 pp from a year earlier.
  • Other income / expenses increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly other income / expenses holds near -$9.37M or moves back toward the trailing-twelve-month quarterly average of -$1.34M.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$9.37M-239.0% QoQ
Last fiscal yearDec 2025
$5.54M-83.4% YoY
LTMMar 2026
-$5.37M-124.3% YoY
Other Income / Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-705.4%——
1 year-83.4%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Income / Expenses history

USD · from the income statement

Latest · FY2025
5.54M USD
Year-over-year change
-83.4%
4-year CAGR
-10.9%

Other Income / Expenses vs competitors

How DTIL compares with its peers on the latest reported figures

  • DTIL's LTM Mar 2026 other income / expenses of -$5.37M is the 6th highest of the 7 companies compared; the peer median is $661.5K.
  • Its year-over-year change of -124.3% is the 4th highest of 6, against a peer median of -87.1%.
  • Other income / expenses amounts to 11.9% of revenue for DTIL, versus a peer median of 13.6%.
DTIL Competitors Peer median
Other Income / Expenses for DTIL and competitors
Company Period LTM YoY 3-year CAGR% of revenue
QTTBQ32 Bio Inc.LTM Mar 2026$11.83M +129.2%—22.0%
ALECAlector, Inc.LTM Mar 2026$11.31M -50.1%-26.8%61.4%
ABOSAcumen Pharmaceuticals, Inc.LTM Mar 2026$1.34M -87.1%+1.6%—
RNAAtrium Therapeutics, Inc.FY2025-$12K ——0.1%
GOSSGossamer Bio, Inc.LTM Mar 2026-$1.7M -138.4%—3.1%
DTILPrecision BioSciences, Inc.LTM Mar 2026-$5.37M -124.3%—11.9%
HRTXHeron Therapeutics, Inc.LTM Mar 2026-$20.48M -386.7%—13.6%
Peer median (excluding DTIL) $661.5K-87.1%-12.6%13.6%

Competitors are the stored peer set for DTIL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue115.53M25.1M48.73M68.7M34.26M
Cost of Revenue00002.75M
Gross Profit115.53M25.1M48.73M68.7M31.51M
Gross Margin100.0%100.0%100.0%100.0%92.0%
Research & Development115.24M46.12M53.38M59.56M54.17M
Selling, General & Admin39.67M41.28M39.09M35.3M32.24M
Operating Expenses154.91M87.41M92.46M94.86M83.66M
Depreciation & Amortization10.2M9M8.26M4.58M2.75M
EBITDA(20.27M)(62.79M)(32.04M)13.53M(42.43M)
EBITDA Margin-17.5%-250.2%-65.8%19.7%-123.8%
Operating Income(39.38M)(62.31M)(43.74M)(26.16M)(52.15M)
Operating Margin-34.1%-248.3%-89.8%-38.1%-152.2%
Interest Income208K3.47M7.69M6.76M4.24M
Interest Expense132K1.11M2.23M1.78M1.42M
Other Income / Expenses8.77M(10.6M)1.21M33.33M5.54M
Income Before Tax(30.6M)(72.91M)(42.53M)7.17M(46.61M)
Pre-Tax Margin-26.5%-290.5%-87.3%10.4%-136.0%
Income Tax Expense00000
Net Income(30.6M)(111.64M)(61.32M)7.17M(46.61M)
Net Margin-26.5%-444.8%-125.8%10.4%-136.0%
EPS (Basic)(15.60)(38.10)(15.96)1.05(3.63)
EPS (Diluted)(15.60)(38.10)(15.96)1.04(3.63)
Weighted Avg Shares1.96M2.93M3.84M6.83M12.83M
Weighted Avg Shares (Diluted)1.96M2.93M3.84M6.88M12.83M

Precision BioSciences, Inc.

NASDAQ:DTIL

Intrinsic Alpha fair value

Locked

Current Price

$7.10

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.